Latest News About Trumprx

Here are the latest highlights on TrumpRx as of now:

• Multiple outlets in early February 2026 reported that TrumpRx is a government-backed portal intended to help consumers access discounted prescription drugs by directing them to manufacturers’ purchasing channels and providing coupons for use at pharmacies. This framing was repeated across several coverage pieces published around February 5–6, 2026.[7][10]
• Reports during 2025 and early 2026 described partnerships with major drugmakers (notably Pfizer and AstraZeneca) to offer certain medications at substantial discounts via TrumpRx, with discounts sometimes framed as 50–85% off list prices in media summaries.[4][6]
• Coverage from CBS News and other outlets in late 2025 highlighted TrumpRx as part of a broader effort to address high U.S. prescription drug costs, while some health-policy experts questioned the platform’s impact and practical effect for consumers.[2][3]

If you want, I can pull more detailed summaries from specific outlets (CBS News, CNBC, HuffPost, etc.), track major updates over the next week, or summarize what TrumpRx might mean for real-world drug pricing and access.